KR100468054B1 - 비만억제용 조성물 - Google Patents
비만억제용 조성물 Download PDFInfo
- Publication number
- KR100468054B1 KR100468054B1 KR10-2002-0051974A KR20020051974A KR100468054B1 KR 100468054 B1 KR100468054 B1 KR 100468054B1 KR 20020051974 A KR20020051974 A KR 20020051974A KR 100468054 B1 KR100468054 B1 KR 100468054B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- weight
- present
- adipose tissue
- parts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 208000008589 Obesity Diseases 0.000 title claims abstract description 11
- 235000020824 obesity Nutrition 0.000 title claims abstract description 11
- 241000218671 Ephedra Species 0.000 claims abstract description 7
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 4
- 230000003579 anti-obesity Effects 0.000 claims description 2
- 241000220304 Prunus dulcis Species 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 239000005864 Sulphur Substances 0.000 claims 2
- 235000020224 almond Nutrition 0.000 claims 2
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 239000000284 extract Substances 0.000 abstract description 4
- 241000195493 Cryptophyta Species 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 17
- 210000000577 adipose tissue Anatomy 0.000 description 16
- 210000001789 adipocyte Anatomy 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 238000007912 intraperitoneal administration Methods 0.000 description 7
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical group C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000034158 bleeding Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 6
- 201000010063 epididymitis Diseases 0.000 description 6
- 229960000395 phenylpropanolamine Drugs 0.000 description 6
- 210000000579 abdominal fat Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000918 epididymis Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940124595 oriental medicine Drugs 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical group CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- MCJGCCFJBOZDAN-UHFFFAOYSA-N 3-butyl-1h-quinolin-2-one Chemical compound C1=CC=C2N=C(O)C(CCCC)=CC2=C1 MCJGCCFJBOZDAN-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
- A23V2200/3324—Low fat - reduced fat content
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
성분 | g |
카제인 | 20 |
슈크로즈 | 10 |
옥수수 전분 | 31 |
Dyetrose | 10 |
라드(80%) | 13.5 |
대두유 | 5.5 |
셀룰로즈 | 5 |
비타민 mix | 1 |
미네랄 mix | 3.5 |
콜린 바이타르타레이트 | 0.2 |
L-시스테인 | 0.3 |
부틸히드록시퀴놀린 | 0.0014 |
합계 | 100 |
g | cal | cal % | |
탄수화물 | 51 | 204 | 47.1284 |
단백질 | 20.54 | 82.16 | 18.98073 |
지방 | 16.3 | 146.7 | 33.89087 |
합계 | 87.84 | 432.86 | 100 |
그룹 | 체중 (g) | 체중 변화량 (g) |
대조군 | 32.253 ±0.948 a | 8.723 ±0.948 a |
실시예 1 | 28.673 ±0.844 b | 5.700 ±0.844 b |
제니칼 | 29.971 ±0.498 ab | 6.111 ±0.498 b |
PPA | 30.747 ±0.459 ab | 7.600 ±0.459 ab |
그룹 | 부고환 지방조직 (g) | 신장후 지방조직 (g) | 복강내 지방조직 (g) |
대조군 | 1.481 ± 0.174 a | 0.558 ± 0.074 a | 2.039 ± 0.244 a |
실시예 1 | 0.827 ± 0.117 b | 0.291 ± 0.045 b | 1.118 ± 0.161 c |
제니칼 | 0.966 ± 0.098 b | 0.328 ± 0.037 b | 1.293 ± 0.130 bc |
PPA | 1.372 ± 0.101 a | 0.370 ± 0.049 b | 1.741 ± 0.127 ab |
그룹 | 복강지방비율(%) |
대조군 | 6.333 ±0.418 a |
SH-21 | 3.774 ±0.447 b |
제니칼 | 4.256 ±0.378 b |
PPA | 5.620 ±0.373 a |
직경 (㎛ ) | 단면적 (㎛2) | |
대조군 | 100.27±7.72a | 9863.52±1469.02a |
실시예 1 | 59.57±2.22c | 3210.34±240.36c |
제니칼 | 63.12±2.12c | 3537.43±222.37c |
PPA | 76.24±4.14b | 5562.14±587.81b |
Claims (2)
- 건조중량비로 마황, 황금, 포황, 석창포, 및 행인 각각 30-60중량부, 하엽 및 원지 각각 15-45중량부로 구성된 비만억제용 조성물
- 건조중량비로 마황, 황금, 포황, 석창포, 및 행인을 각각 30-60중량부, 하엽 및 원지를 각각 15-45중량부를 혼합한 다음, 100℃에서 3시간이상 열수 추출하고, -40℃ 이하에서 10시간이상 급속동결하고, -40℃ 이하에서 0.2토르 이하의 압력하에서 진공건조한 다음 분쇄하는 것으로 구성되는 비만억제용 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051974A KR100468054B1 (ko) | 2002-08-30 | 2002-08-30 | 비만억제용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051974A KR100468054B1 (ko) | 2002-08-30 | 2002-08-30 | 비만억제용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040020376A KR20040020376A (ko) | 2004-03-09 |
KR100468054B1 true KR100468054B1 (ko) | 2005-01-24 |
Family
ID=37324842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0051974A KR100468054B1 (ko) | 2002-08-30 | 2002-08-30 | 비만억제용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100468054B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5118292B2 (ja) * | 2005-06-16 | 2013-01-16 | 株式会社ロッテ | 脂肪分解促進剤 |
WO2019083225A1 (ko) * | 2017-10-23 | 2019-05-02 | 이영구 | 한방 다이어트 관리 시스템 및 그 방법 |
KR101888478B1 (ko) * | 2018-02-23 | 2018-08-14 | 주식회사 위드내추럴 | 한약재를 이용한 체중감량용 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980067315A (ko) * | 1997-02-03 | 1998-10-15 | 김달래 | 뚱뚱한 사람이 섭취하는 다이어트 건강식품의 제조방법 |
KR19990011833A (ko) * | 1997-07-25 | 1999-02-18 | 김이현 | 부인과 질환 및 여성비만 치료용 약제 조성물과 이를 이용한 약제의 제조방법 |
KR20010017482A (ko) * | 1999-08-11 | 2001-03-05 | 신상국 | 다이어트용 음료조성물 및 그 제조방법 |
KR20020037218A (ko) * | 2000-11-13 | 2002-05-18 | 황성연 | 한약재 증류수를 이용한 다이어트 음료수 제조방법 |
-
2002
- 2002-08-30 KR KR10-2002-0051974A patent/KR100468054B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980067315A (ko) * | 1997-02-03 | 1998-10-15 | 김달래 | 뚱뚱한 사람이 섭취하는 다이어트 건강식품의 제조방법 |
KR19990011833A (ko) * | 1997-07-25 | 1999-02-18 | 김이현 | 부인과 질환 및 여성비만 치료용 약제 조성물과 이를 이용한 약제의 제조방법 |
KR20010017482A (ko) * | 1999-08-11 | 2001-03-05 | 신상국 | 다이어트용 음료조성물 및 그 제조방법 |
KR20020037218A (ko) * | 2000-11-13 | 2002-05-18 | 황성연 | 한약재 증류수를 이용한 다이어트 음료수 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20040020376A (ko) | 2004-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
KR20190110229A (ko) | 천연재료 추출물을 유효성분으로 하는 여성 갱년기 증후군 개선용 조성물 및 그의 제조방법 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
KR100601390B1 (ko) | 혼합 생약재를 이용한 비만 억제용 조성물 | |
KR101456937B1 (ko) | 천연물 추출물로 구성된 비만의 억제 및 치료용 조성물 | |
CN103041410B (zh) | 一种用于胃肠道超声诊断的造影粉剂 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN110652552A (zh) | 一种伤口愈合配方及制备方法 | |
KR100468054B1 (ko) | 비만억제용 조성물 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN105596587A (zh) | 用于消肿止痛的组合物 | |
CN101249186A (zh) | 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法 | |
KR100514132B1 (ko) | 체중 감소용 생약 조성물 및 이를 포함하는 체중 감소용 키트 | |
TWI728304B (zh) | 滋陰補腎組合物及其製備方法與應用 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 | |
CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
KR100504124B1 (ko) | 비만억제용 조성물 | |
CN103690816B (zh) | 消除脾虚痰湿乳房囊性增生的中药组合物及其制备方法 | |
CN104800546A (zh) | 一种治疗风湿性心脏病的中药制剂及其制备方法 | |
CN105125926A (zh) | 用于治疗烧烫伤的药粉及制备方法 | |
CN103550337B (zh) | 治疗女性月经不调的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130111 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140115 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150112 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160108 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170106 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190108 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20200109 Year of fee payment: 16 |